• Much more than a ‘party drug’

  • Jun 7 2023
  • Duración: 36 m
  • Podcast

Much more than a ‘party drug’  Por  arte de portada

Much more than a ‘party drug’

  • Resumen

  • Psilocybin, MDMA or LSD might associate with party drugs but their therapeutic value is being discovered worldwide. Ian Roullier took part in two clinical trials that looked at the effects of psilocybin on depression. Through his personal experience, Roullier shares his insights on psychedelic-assisted therapy, its potential value to patients and what is needed to boost research in this field.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Much more than a ‘party drug’

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.